ALNY
Alnylam Pharmaceuticals Inc
224.50$
+0.1%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 11,242.0% | 797.1% | 806.0% | 232.5% | 267.6% | 123.1% | 141.9% | 136.9% | 160.0% | 184.1% | 284.5% | 454.5% | 804.0% | 980.0% | 643.0% | 2.4% | 11.4% | 15.8% | 16.6% | 16.3% | 17.0% | 14.4% | 18.2% | |
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 97.6% | 88.6% | 84.2% | 83.4% | 83.7% | 83.0% | 85.6% | 81.8% | |
| – | 7,441.5% | 575.1% | 617.9% | 184.9% | 237.1% | 100.7% | 108.2% | 106.3% | 120.0% | 129.7% | 239.5% | 376.3% | 672.8% | 810.9% | 434.5% | 674.7% | 298.1% | 132.9% | 93.8% | 85.1% | 54.9% | 50.1% | 35.7% | |
| – | 4,276.7% | 279.1% | 242.6% | 61.8% | 46.0% | 28.2% | 39.7% | 37.7% | 46.3% | 66.9% | 57.6% | 88.1% | 147.5% | 189.5% | 221.7% | 510.4% | 218.0% | 119.4% | 73.5% | 74.3% | 43.5% | 43.4% | 32.6% | |
| – | 11,718.2% | 854.2% | 860.5% | 246.7% | 283.1% | 128.9% | 147.9% | 144.1% | 166.2% | 196.6% | 297.0% | 464.3% | 820.3% | 1,000.3% | 656.2% | 1,185.2% | 516.1% | 252.3% | 167.3% | 159.4% | 98.5% | 93.5% | 68.3% | |
| – | -14,236.9% | -754.2% | -760.5% | -146.7% | -183.1% | -28.9% | -47.9% | -44.1% | -66.2% | -194.0% | -197.0% | -801.0% | -720.3% | -900.3% | -556.2% | -1,087.6% | -427.5% | -168.1% | -83.9% | -75.7% | -15.4% | -7.9% | 13.5% | |
| – | 0.0% | 15.5% | 17.0% | 3.8% | 2.1% | 0.9% | 5.4% | 2.3% | 1.5% | 1.5% | 2.3% | 5.1% | 14.3% | 17.6% | 13.6% | 39.1% | 49.4% | 17.1% | 16.9% | 15.0% | 6.6% | 6.3% | 6.8% | |
| – | -16,871.6% | -826.7% | -750.8% | -128.5% | -157.6% | -26.5% | -46.8% | -43.0% | -69.7% | -174.7% | -194.9% | -792.3% | -705.8% | -869.6% | -545.9% | -1,015.5% | -402.8% | -173.6% | -100.9% | -108.6% | -23.7% | -16.8% | 8.7% | |
| – | -2,605.1% | 9.1% | -9.8% | -18.2% | 10.3% | 0.7% | 0.6% | 0.5% | -7.0% | -15.8% | -5.7% | -79.5% | -60.6% | -49.7% | -28.5% | 1.1% | 0.4% | 0.5% | 0.1% | 0.4% | 0.4% | -4.4% | 0.3% | |
| – | -14,223.3% | -763.3% | -750.8% | -128.5% | -167.9% | -27.3% | -47.3% | -43.5% | -69.7% | -158.9% | -189.2% | -712.8% | -705.8% | -869.6% | -545.9% | -1,016.6% | -403.2% | -174.1% | -101.0% | -109.0% | -24.1% | -12.4% | 8.4% | |
| – | -11,142.0% | -690.7% | -679.3% | -132.5% | -147.5% | -19.7% | -40.8% | -38.0% | -60.0% | -77.5% | -175.4% | -340.8% | -673.9% | -868.2% | -541.3% | -1,006.9% | -402.8% | -149.4% | -78.4% | -89.3% | -14.1% | -8.0% | 17.0% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.